# Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children

> **NCT00781521** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 96 (actual)

## Conditions studied

- Otitis Media

## Interventions

- **DRUG:** ofloxacin otic solution 0.3%

## Key facts

- **NCT ID:** NCT00781521
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2008-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781521, "Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00781521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
